Hospital Clínico San Carlos

Futó vizsgálatok

• Még nem toboroz

  Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors

  NCT06139783· Oncare Madrid· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.

  NCT07480395· W.L.Gore & Associates· Forrás

• Még nem toboroz

  A study to compare heart failure medicines in one combined pill with usual care.

  2026-526510-90-00· 3. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Még nem toboroz

  A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC

  2026-526300-67-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Még nem toboroz

  Rimonabant for Improving Walking Ability in Patients With Chronic Stroke

  NCT07913763· 2. fázis· Sinfatin S.L· Forrás

• Még nem toboroz

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Evaluation of the Safety and Efficacy of Rimonabant on Cognitive impairment in patients with post-COVID-19 Syndrome.

  2023-507870-42-00· 2. fázis· Sinfatin S.L.· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes

  NCT07401901· Medtronic MiniMed, Inc.· Forrás

• Toboroz

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· 1/2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.

  2025-525030-57-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study

  NCT07635537· Hospital San Carlos, Madrid· Forrás

• Még nem toboroz

  A study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis

  2026-526184-38-00· 2. fázis· Enveda Therapeutics Inc.· Forrás

• Még nem toboroz

  Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)

  NCT07247786· 2. fázis· Fundación GECP· Forrás

• Még nem toboroz

  Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning

  NCT06113939· 4. fázis· Hospital San Carlos, Madrid· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Még nem toboroz

  Effects of a CB1 Antagonist/Inverse Agonist (Rimonabant) on Functional Recovery in Stroke Patients During Subacute Phase.

  2025-521689-86-00· 2. fázis· Sinfatin S.L.· Forrás

• Toboroz

  A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  NCT07807163· 2. fázis· Bicara Therapeutics· Forrás

• Még nem toboroz

  Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

  NCT07717099· 2. fázis· Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD· Forrás

• Még nem toboroz

  Multicentre, randomized, open label study comparing the concomitant administration of trabectedin and low-dose radiotherapy versus trabectedin alone in patients with advanced sarcoma

  2026-525703-27-00· 4. fázis· Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  2025-524711-36-00· 3. fázis· Alkermes Inc.· Forrás

• Toboroz

  A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.

  NCT07460986· 1/2. fázis· MedSIR· Forrás

• Toboroz

  A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.

  2025-524488-18-00· 2. fázis· Astellas Pharma Global Development Inc.· Forrás

• Toboroz

  A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

  NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  NCT07636811· 2. fázis· Alnylam Pharmaceuticals· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

  2025-524336-19-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  NCT07625644· 3. fázis· SystImmune Inc.· Forrás

• Toboroz

  BGB-43395 in Combination with Letrozole versus CDK4/6i with Letrozole for Patients with Previously Untreated Advanced or Metastatic HR+/HER2- Breast Cancer

  NCT07492641· 3. fázis· BeOne Medicines I GmbH· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

  2025-523912-35-00· 3. fázis· Alkermes Inc.· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  2025-523911-13-00· 3. fázis· Alkermes Inc.· Forrás

• Toboroz

  Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

  NCT07566624· Fundación EPIC· Forrás

• Toboroz

  Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

  NCT07478991· 3. fázis· PETHEMA Foundation· Forrás

• Toboroz

  Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  NCT07476287· 2. fázis· Pfizer· Forrás

• Toboroz

  BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])

  NCT07666490· 4. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916· 3. fázis· ViiV Healthcare· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

  NCT07365319· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Toboroz

  Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

  NCT07333066· 3. fázis· Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD· Forrás

• Toboroz

  Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

  NCT07403825· 4. fázis· Biobizkaia Health Research Institute· Forrás

• Toboroz

  Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

  NCT07242547· 2. fázis· Fundación GECP· Forrás

• Toboroz

  Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  NCT07566156· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer

  2025-521460-36-00· 4. fázis· Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

  NCT07545759· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Még nem toboroz

  REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices

  NCT07611188· Puerta de Hierro University Hospital· Forrás

• Még nem toboroz

  Clinical Trial To Evaluate The Safety And Efficacy Of Dasatinib To Reduce HIV-1 Reservoir, Chronic Inflammation, And Immune Senescence In People With HIV On Long-Term Antiretroviral Treatment.

  2025-524363-20-01· 2. fázis· Instituto De Salud Carlos III· Forrás

Showing 50 of 404.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák45 toboroz
• Áttétes emlőrák18 toboroz
• Prosztatarák18 toboroz
• Hólyagrák14 toboroz
• Petefészekrák11 toboroz
• Alzheimer-kór10 toboroz
• Fej-nyaki daganatok9 toboroz
• Stroke (szélütés)9 toboroz
• Szívelégtelenség9 toboroz
• Vastagbélrák9 toboroz
• Gyomor- és nyelőcsőrák8 toboroz
• Koszorúér-betegség8 toboroz
• Aortic stenosis7 toboroz
• Gyermekkori daganatok6 toboroz
• Hasnyálmirigyrák6 toboroz
• Méhtestrák6 toboroz
• Pitvarfibrilláció6 toboroz
• Sclerosis multiplex (SM)6 toboroz
• Szarkóma6 toboroz
• Melanóma5 toboroz
• Vesedaganat5 toboroz
• Elhízás4 toboroz
• Méhnyakrák4 toboroz
• Migrén4 toboroz
• Narcolepsy4 toboroz
• Epilepszia3 toboroz
• Irritable bowel syndrome3 toboroz
• Skizofrénia3 toboroz
• Zöldhályog (glaukóma)3 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Asztma2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Endometriózis2 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• HIV-fertőzés2 toboroz
• Idiopátiás tüdőfibrózis2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Lupus (SLE)2 toboroz
• Máj- és epeúti rák2 toboroz
• Mielóma multiplex2 toboroz
• Pajzsmirigyrák2 toboroz
• Rheumatoid arthritis2 toboroz
• Tripla negatív emlőrák2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Aortic aneurysm1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Csontritkulás1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Dilated cardiomyopathy1 toboroz
• Down syndrome1 toboroz
• Follikuláris limfóma1 toboroz
• Frontotemporális demencia1 toboroz
• Glioblasztóma1 toboroz
• Graves' disease and hyperthyroidism1 toboroz
• Időskori makuladegeneráció1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Long COVID és ME/CFS1 toboroz
• Mezotelióma1 toboroz
• Myasthenia gravis1 toboroz
• Obstructive sleep apnoea1 toboroz
• Parkinson-kór1 toboroz
• Peripheral artery disease1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Sjögren-szindróma1 toboroz
• Thalassaemia1 toboroz

Lezárt vizsgálatok

• Lezárult

  Evaluation of the Risk of Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

  NCT07719621· Aeterna Medical Solutions SL· Forrás

• Lezárult

  NutriTrack: AI-Assisted Nutritional Tracking in the Obesity Clinic

  NCT07588620· Francisco José García González· Forrás

• Lezárult

  A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

  2025-524038-24-00· 3. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  Clinical trial in multiple hospitals to explore new ways to diagnose and monitor tuberculosis treatment

  2025-522235-34-00· 4. fázis· Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz· Forrás

• Lezárult

  A Study Evaluating BFB759 in Atopic Dermatitis

  2025-521624-30-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Lezárult

  A trial to find the effect of Ginkgo biloba extract EGb 761® and how safe it is in participants with cognitive impairment associated with post COVID-19 syndrome

  2024-517199-39-00· 2. fázis· Dr. Willmar Schwabe GmbH & Co. KG· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

  2024-512505-66-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Fut, nem toboroz

  Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  NCT06806293· 3. fázis· AbbVie· Forrás

• Lezárult

  N/A

  2024-513121-22-00· 2. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated ROS1-Positive Non-small Cell Lung Cancer (NSCLC)

  NCT05828303· 1. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Lezárult

  A study to compare effects and safety of CT-P51 and Keytruda in patients with previously untreated metastatic lung cancer

  2024-514048-98-00· 3. fázis· Celltrion Inc.· Forrás

• Lezárult

  A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

  NCT06723288· Hoffmann-La Roche· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

  2024-514559-13-00· 2/3. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open- labeled Long-term Extension Treatment with Aticaprant

  2024-511557-21-00· 3. fázis· Janssen Cilag International· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· AbbVie· Forrás

• Lezárult

  A study to investigate the safety and pharmacological effect of a single intravenous infusion of GSK2857914 in male and female participants aged 18 to 75 with moderate to severe systemic lupus erythematosus

  NCT06413511· 1. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Leállították

  Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

  NCT06524739· 3. fázis· CSL Behring· Forrás

• Lezárult

  A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer

  2023-506882-70-00· 3. fázis· H e x a l AG· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

  NCT06483334· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib

  NCT06200714· Boehringer Ingelheim· Forrás

• Lezárult

  A study to compare effectiveness and safety of a combination of vudalimab or pembrolizumab with chemotherapy in participants with advanced lung cancer.

  NCT06173505· 1/2. fázis· Xencor Inc.· Forrás

• Leállították

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

  NCT06444451· 2. fázis· Sanofi· Forrás

• Lezárult

  A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoriasis

  2023-508992-35-00· 2. fázis· Janssen Cilag International· Forrás

• Lezárult

  A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

  NCT06395753· 2. fázis· Debiopharm International SA· Forrás

• Lezárult

  A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

  NCT06188559· 2. fázis· Eisai Inc.· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

  NCT06168409· 3. fázis· AstraZeneca· Forrás

• Lezárult

  THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)

  2023-507304-32-00· 4. fázis· Fundacio Privada Mon Clinic Barcelona· Forrás

• Lezárult

  VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

  NCT06214052· 2. fázis· ViiV Healthcare· Forrás

• Lezárult

  Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

  NCT05962606· 2. fázis· Aptarion Biotech AG· Forrás

• Fut, nem toboroz

  Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

  NCT05853575· 2. fázis· Mirati Therapeutics Inc.· Forrás

• Lezárult

  An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

  NCT06179875· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Lezárult

  Multicenter Phase 2 study to evaluate the efficacy and safety of Cetuximab in combination with Encorafenib plus Binimetinib as induction treatment in BRAF (V600E) mutated MSS, initially resectable or potentially resectable advanced colorectal cancer: CEBBRA study.

  2022-502413-29-00· 2. fázis· Asociacion Grupo Tratamiento De Tumores Digestivos· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Pfizer· Forrás

• Lezárult

  A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma.

  NCT04718675· 1. fázis· Kronos Bio Inc.· Forrás

• Lezárult

  Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

  NCT05913193· Abbott Nutrition· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

  NCT06034743· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· 3. fázis· Mineralys Therapeutics Inc.· Forrás

• Lezárult

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· 3. fázis· Takeda· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

  NCT06073119· 2. fázis· Sanofi· Forrás

• Lezárult

  Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

  NCT06039579· 2. fázis· ViiV Healthcare· Forrás

• Lezárult

  Development of a Molecular Diagnostic Tool for Endometrial Cancer.

  NCT06192017· MiMARK Diagnostics, S.L.· Forrás

• Fut, nem toboroz

  A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

  NCT05904886· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

  2022-502828-42-00· 2. fázis· Genentech Inc.· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

  NCT05909904· 2. fázis· BeiGene· Forrás

• Fut, nem toboroz

  Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

  NCT05968430· 3. fázis· Mineralys Therapeutics Inc.· Forrás

Showing 50 of 175.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Sclerosis multiplex (SM)35 munka · 21 vizsgálat
• Aortic stenosis24 munka · 11 vizsgálat
• Zöldhályog (glaukóma)23 munka · 7 vizsgálat
• Bronchiectasis9 munka · 0 vizsgálat
• Fibromyalgia8 munka · 0 vizsgálat
• Coeliac disease7 munka · 0 vizsgálat
• Thalassaemia5 munka · 1 vizsgálat